Article
Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.
Journal of medical case reports - 10 Feb 2024
Kosumi Takuya, Kobayashi Masanori, Shimodaira Shigetaka, Sugiyama Haruo, Koido Shigeo
Abstract excerpt
BACKGROUND: Satisfactory treatment for patients with unresectable advanced lung cancer has not yet been established. We report a case of unresectable advanced lung cancer (stage IIIb: T2aN3M0) treated with a total of 15 doses of dendritic cells pulsed with a Wilms' tumor 1 and mucin 1 vaccine in combination with erlotinib, a small molecule epidermal growth factor receptor tyrosine kinase inhibitor, for more than...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
